Turning Cancer Data into Action: NCI-K Champions Mandatory Cancer Reporting at the 9th Kenya International Cancer Conference.

19th Nov 2026

MOMBASA, KENYA — November 19, 2026 — The NATIONAL CANCER INSTITUTE OF KENYA (NCI-K) has called upon all public and private healthcare facilities across the country to uphold their statutory duty of mandatory cancer reporting, emphasizing that verified, real-world data is the cornerstone of effective cancer control and patient survival.

Delivering a keynote presentation on the opening day of the 9th Kenya International Cancer Conference (KICC 2026)—hosted by the Kenya Society of Haematology & Oncology (KESHO) in Mombasa- Mrs. Gladys Chesumbai , Head of the National Cancer Registry at NCI-K, highlighted the urgent need to bridge the gap between clinical diagnosis and national policy.

Speaking in alignment with the conference theme, “Equity, Excellence, and Sustainable Impact in Cancer Care,” Mrs. Chesumbai outlined how comprehensive cancer surveillance powers Kenya’s National Cancer Control Strategy (2023–2027).

Cancer Control Begins with Knowing the Burden

Guided by the strategic thesis that “a country cannot plan an effective response to a burden it cannot see clearly,” NCI-K’s National Cancer Registry operates on a three-pillar framework:

  • SEE: Identifying exact cancer types by geographic location and population demographics.
  • UNDERSTAND: Uncovering disease patterns, service delivery gaps, and healthcare inequities across counties.
  • ACT: Aligning national health policy, clinical services, and targeted investments—such as the Social Health Authority (SHA) Enhanced Cancer Benefits Package—to meet actual population needs.

Kenya’s Cancer Landscape: Insights from Registry & GLOBOCAN Data

During her presentation, Mrs. Chesumbai shared critical epidemiological insights highlighting where Kenya’s cancer burden is most concentrated:

Article content
Top Five Cancer Data Presentation
  • Top Five Cancers Drive Over Half of All Cases: According to GLOBOCAN 2024 incidence and mortality data presented at the forum, five cancers account for 52.3% of all cancer cases in Kenya: Breast Cancer: 16.2% (6,822 new cases; 2,882 annual deaths) Cervical Cancer: 12.0% (4,294 new cases; 2,606 annual deaths) Prostate Cancer: 10.0% (3,661 new cases; 2,136 annual deaths) Oesophageal Cancer: 7.1% (2,532 new cases; 2,353 annual deaths) Colorectal Cancer: 7.0% (2,525 new cases; 1,411 annual deaths)
  • County-Level Surveillance: Data from the 2024 national registry tracking illustrates how mapping cases by county of residence—led by Nairobi (1,428 cases), Kiambu (947), Nakuru (854), Nyeri (844), and Meru (841)—enables health authorities to identify high-burden regions and tailor county-level interventions.

A Statutory National Responsibility

Mrs. Chesumbai reminded clinicians, pathologists, laboratory specialists, and hospital administrators that cancer notification is not optional. Under the Cancer Prevention and Control Act (2012), Cap. 246B, cancer reporting is mandatory across all health facilities in Kenya.

To achieve a truly comprehensive National Cancer Registry, NCI-K is enforcing four key operational standards:

Article content
Statutory Responsibility Presentation
  • Universal Coverage: A binding reporting duty across both public and private health facilities.
  • Seamless Pathways: Establishing direct digital and operational links from diagnosis to capture in the National Cancer Registry.
  • Multidisciplinary Alignment: Ensuring coordinated reporting among attending clinicians, pathologists, and diagnostic laboratories.
  • System Accountability: Maintaining audited quality standards for complete, accurate, and timely data submission.

Translating Evidence into Lifesaving Impact

Concluding her address on “From Cancer Data to Decisions That Save Lives,” Mrs. Chesumbai demonstrated how verified registry evidence directly informs on-the-ground action:

  1. Policy & Priorities: Guiding targeted community screening and early detection outreach for high-burden cancers across counties.
  2. Planning & Investment: Supporting the equitable deployment and equipping of regional cancer centers across the country.
  3. Accountability & Survivorship: Tracking treatment outcomes and measurable survival gains over time to improve cancer survivors’ quality of life.

As KICC 2026 continues in Mombasa through November 21, the National Cancer Institute of Kenya remains committed to collaborating with healthcare providers, researchers, county governments, and development partners to strengthen cancer surveillance and build a healthier, cancer-free nation.

NEWSLETTER

Hear from us regularly

Whether you are a patient, caregiver, healthcare provider, or advocate, our resources are here to support you. Explore our materials, stay informed, and join us in the fight against cancer.